Demand for Formulation technology to bind loose fat without affecting of Orlistat

The "TOP 10 Global Pharma Company" is seeking:

Ingredient or formulation technology to bind the loose fat in the bowels without affecting efficacy of Orlistat.

They are looking for potential partners with unique innovative technologies to meet changing needs of global consumers. Seeker is the leading research-based pharmaceutical and healthcare company , employing  100,000+  people in 100+  countries. 

Your product innovation combined with additional scientific expertise and world-class marketing can help them deliver innovative Consumer Healthcare brands around the world.  Seeker is committed to Open Innovation R&D  model.

Open Innovation is process for linking of external ideas or innovative technology with internal R&D and commercial team responsible to grow new innovative and branded products..

First you should  submit non-coofidential information about your innovative product or technology. Once submitted, your innovation idea is assigned to an Technology Transfer Manager at Farmavita.Net to guide the idea through early stage of assessment. After positive initial assessment  you will be asked for an agency agreement with Farmavita.Net, to authorize us to manage you thorough the process of licensing negotiations. 

Contact us for more details or to submit your non-confidential proposal!   

• Valuing Pharmaceutical Innovation (14/10/2008)
• Respiratory Disorders (14/10/2008)
• Rx-to-OTC Strategies (10/10/2008)

• Pain Management, Arthritis and Gynaecology Segment (02/06/2008)
• Urology products demand (04/01/2008)
• Innovative NCE (16/06/2006)